1. Home
  2. INVZ vs PMN Comparison

INVZ vs PMN Comparison

Compare INVZ & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innoviz Technologies Ltd. Ordinary shares

INVZ

Innoviz Technologies Ltd. Ordinary shares

HOLD

Current Price

$0.68

Market Cap

144.1M

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$11.09

Market Cap

115.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INVZ
PMN
Founded
2016
2004
Country
Israel
Canada
Employees
415
N/A
Industry
Auto Parts:O.E.M.
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
144.1M
115.5M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
INVZ
PMN
Price
$0.68
$11.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$2.68
$42.67
AVG Volume (30 Days)
2.1M
39.2K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$29.61
N/A
Revenue Next Year
$53.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.58
$0.29
52 Week High
$2.54
$27.40

Technical Indicators

Market Signals
Indicator
INVZ
PMN
Relative Strength Index (RSI) 49.30 37.47
Support Level $0.61 $10.55
Resistance Level $0.72 $13.80
Average True Range (ATR) 0.06 0.84
MACD 0.01 0.18
Stochastic Oscillator 51.44 16.72

Price Performance

Historical Comparison
INVZ
PMN

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: